MedPath

Postoperative Analgesic Efficacy of Tetracaine Hydrochloride Gel

Not Applicable
Completed
Conditions
Hysteroscopy
Interventions
Registration Number
NCT02863679
Lead Sponsor
Wenzhou Medical University
Brief Summary

This study was taken out to assess the postoperative analgesic efficacy of tetracaine hydrochloride gel in patients with intrauterine adhesion treating with intrauterine balloon.Participates were assigned into two groups by randomly-tetracaine hydrochloride gel group and control group.

Detailed Description

Tetracaine hydrochloride gel contains 1% tetracaine hydrochloride, and a fair dose of fungicide, lubricants, remove foam agent, as the long-term local anesthetics. Patients in getracaine hydrochloride gel group were covered with a gauze of tetracaine hydrochloride gel on the external cervical orifice after insert an utrauterine balloon in the uterine cavity. While patients in the control group were covered with a blank gauze after hysteroscopic adhesiolysis. Compare the postoperative analgesic scor and patients' analgesic satisfaction of the two groups and asess the analgesic efficacy of tetracaine hydrochloride gel.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
84
Inclusion Criteria
  • no previous history of hysteroscopic adhesiolysis or surgery on the cervix
  • inserted intrauterine balloon in the uterine cavity after hysteroscopic adhesiolysis
  • no other diseases
Exclusion Criteria
  • Allergy to local anesthetics
  • Patients with chronic pain
  • Patients with abnormal blood coagulation function
  • Patients with mental illness that can not cooperate
  • Patients with previous hysteroscopic adhesiolysis or cervical surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Tetracaine hydrochloride gel groupTetracaine hydrochloride gelPatients in getracaine hydrochloride gel group were covered with a gauze with tetracaine hydrochloride gel on the cervix after hysteroscopic insertion of utrauterine balloon stent.
Control groupTetracaine hydrochloride gelPatients in control group were covered with a gauze with saline on the cervix after hysteroscopic insertion of utrauterine balloon stent.
Primary Outcome Measures
NameTimeMethod
Numerical Rating Scale (NRS) score7 days
Secondary Outcome Measures
NameTimeMethod
patients received balloon volume reduction1 day

Trial Locations

Locations (1)

the 1st Affiliated Hospital of Wenzhou Medical College

🇨🇳

Wenzhou, Zhejiang, China

© Copyright 2025. All Rights Reserved by MedPath